Mice with a disruption to BMAL1 exhibit impaired glucose tolerance and decreased insulin secretion, resulting in hyperglycemia and a higher risk for type 2 diabetes mellitus compared with wild-type mice (27). Here, INS is linked to diabetes mellitus.